M.RossiterJ
Clinical studies have demonstrated that GLP-1 receptor agonists like semaglutide and tirzepatide are most effective when combined with diet and exercise
However, for patients who chose not to pursue weight loss during Step Two, Step Three is condensed to three monthly sessions and focuses specifically on preventing binge-eating relapse
B.ElbrondB.RolanP.ZdravkovicM
Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes (T1DM)
The combination is used in research examining the downstream effects of simultaneous GHRH receptor and growth hormone secretagogue receptor activation in cell-based assays